Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 282 citing Cauley: Elevated serum estradiol and testosterone concentrations are associated with a high.... (0.11 sec) 

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from …


SR Cummings, S Eckert, KA Krueger, D Grady, … - Jama, 1999 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ...
Cited by 1451 - Related articles - BL Direct - All 8 versions

International consensus panel on the treatment of primary breast cancer

- ascopubs.org [PDF] 
A Goldhirsch, WC Wood, HJ Senn, JH Glick, … - European Journal of Cancer, 1995 - Elsevier
3. Early Breast Cancer Trialists' Collaborative Group, Systemic treatment for
early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised
trials involving 31000 recurrences and 24000 deaths among 75000 women. ...
Cited by 1050 - Related articles - BL Direct - All 27 versions

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4- …


JA Cauley, L Norton, ME Lippman, S Eckert, … - Breast cancer research and treatment, 2001 - Springer
Breast Cancer Research and Treatment 65: 125–134, 2001. © 2001 Kluwer
Academic Publishers. Printed in the Netherlands. ... Continued breast cancer
risk reduction in postmenopausal women treated with raloxifene: 4-year ...
Cited by 516 - Related articles - BL Direct - All 6 versions

[CITATION] Estrogen and the risk of breast cancer


M Clemons, P Goss - The New England journal of medicine, 2001 - nejm.highwire.org
Experimental data strongly suggest that estrogens have a role in the development
and growth of breast cancer. 2 Although the exact mechanisms remain to be fully
elucidated, the alkylation of cellular molecules and the generation of ...
Cited by 455 - Related articles - BL Direct - All 8 versions

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal …

- oxfordjournals.org
S Martino, JA Cauley, E Barrett-Connor, TJ … - JNCI Journal of the National Cancer Institute, 2004 - jnci.oxfordjournals.org
Background: The randomized, double-blind Multiple Outcomes of Raloxifene
Evaluation (MORE) trial found that 4 years of raloxifene therapy decreased the
incidence of invasive breast cancer among postmenopausal women with ...
Cited by 236 - Related articles - BL Direct - All 9 versions

Weight loss in breast cancer patient management

- jcojournal.org
RT Chlebowski, E Aiello, A McTiernan - Journal of Clinical Oncology, 2002 - jcojournal.org
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
From the Harbor–University of California Los Angeles Research and ...
Cited by 208 - Related articles - BL Direct - All 9 versions

Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology …

- oxfordjournals.org
CJ Fabian, BF Kimler, CM Zalles, JR Klemp, … - JNCI Journal of the National Cancer Institute, 2000 - jnci.oxfordjournals.org
Background: Biomarkers are needed to refine short-term breast cancer risk
estimates from epidemiologic models and to measure response to prevention
interventions. The purpose of our study was to determine whether the ...
Cited by 197 - Related articles - BL Direct - All 10 versions

Serum estradiol level and risk of breast cancer during treatment with raloxifene


SR Cummings, T Duong, E Kenyon, JA Cauley … - Jama, 2002 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context As endogenous ...
Cited by 179 - Related articles - BL Direct - All 8 versions

Effect of oral androstenedione on serum testosterone and adaptations to resistance training …

- ucsf.edu [PDF] 
DS King, RL Sharp, MD Vukovich, GA Brown, … - Jama, 1999 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Androstenedione, ...
Cited by 161 - Related articles - BL Direct - All 9 versions

Osteoporosis due to cancer treatment: pathogenesis and management

- jcojournal.org
J Pfeilschifter, IJ Diel - Journal of Clinical Oncology, 2000 - jcojournal.org
ABSTRACT: Many therapeutic regimens in cancer treatment carry the risk of
causing or favoring the development of osteoporosis. Therapies in which
hypogonadism may occur are most relevant in this respect. Prompt hormone ...
Cited by 154 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google